Patents by Inventor Wolfgang Dummer

Wolfgang Dummer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090169550
    Abstract: A method is disclosed of treating a rituximab-refractory rheumatoid arthritis (RA) patient comprising administering an anti-CD20 antibody other than rituximab to the patient in an amount effective to treat the RA.
    Type: Application
    Filed: December 19, 2008
    Publication date: July 2, 2009
    Applicant: Genentech, Inc.
    Inventor: WOLFGANG DUMMER
  • Publication number: 20080299117
    Abstract: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg effective to deplete B cells in the patient.
    Type: Application
    Filed: May 21, 2008
    Publication date: December 4, 2008
    Inventors: Hal V. Barron, Andrew C. Chan, Daniel Combs, Wolfgang Dummer, Paul J. Fielder, Gwendolyn Fyfe
  • Publication number: 20080095771
    Abstract: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies effective to deplete B cells in the patient.
    Type: Application
    Filed: October 30, 2007
    Publication date: April 24, 2008
    Applicant: Genentech, Inc.
    Inventors: Hal Barron, Andrew Chan, Daniel Combs, Wolfgang Dummer, Paul Fielder, Gwendolyn Fyfe
  • Publication number: 20060188495
    Abstract: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies effective to deplete B cells in the patient.
    Type: Application
    Filed: January 12, 2006
    Publication date: August 24, 2006
    Inventors: Hal Barron, Andrew Chan, Daniel Combs, Wolfgang Dummer, Paul Fielder, Gwendolyn Fyfe
  • Patent number: 6037504
    Abstract: In a process for producing aliphatic .alpha.,.omega.-diols comprising 4 to 12 C atoms from aliphatic .alpha.,.omega.-dicarboxylic acids comprising 4 to 12 C atoms, an oligoester of average chain length n=3 to n=4.5 and with an acid number of 40 to 60 mg KOH/g reaction mixture is first formed from a diol and a dicarboxylic acid, which oligoester is thereafter catalytically hydrogenated in the liquid phase. Hydrogenation is carried out continuously at 180 to 250.degree. C. and at an H.sub.2 pressure of 100 to 400 bar, over a pelletised catalyst which is free from Zn oxide and which comprises pressed powders of Cu, Mn and Al oxides with a content of at least one oxide of metals of subgroup VI of the periodic table of the elements (Mendeleev). The amount of H.sub.2 is 20 to 100 times the amount required stoichiometrically.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: March 14, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Gerhard Darsow, Wolfgang Dummer, Wilfried Niemeier
  • Patent number: 5300643
    Abstract: New quinolone-carboxylic acids of the general formula (I) ##STR1## wherein the definitions for R.sub.1 -R.sub.9 are given in the description, a process for their preparation and their use as medicaments, in particular as antiviral agents.
    Type: Grant
    Filed: August 25, 1992
    Date of Patent: April 5, 1994
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus Grohe, Wolfgang Dummer, Kai Rossen, Arnold Paessens
  • Patent number: 5217972
    Abstract: New quinolone-carboxylic acids of the general formula (I) ##STR1## wherein the definitions for R.sub.1 -R.sub.9 are given in the description, a process for their preparation and their use as medicaments, in particular as antiviral agents.
    Type: Grant
    Filed: September 19, 1990
    Date of Patent: June 8, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus Grohe, Wolfgang Dummer, Kai Rossen, Arnold Paessens